CoChat

Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?

Open access
Trabert, Britton, Wentzensen, Nicolas, Yang, Hannah P., Sherman, Mark E., Hollenbeck, Albert R., Park, Yikyung, Brinton, Louise A. · 2013 · International Journal of Cancer
Cited by 71

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Given the strong link between use of unopposed estrogens and development of endometrial cancers, estrogens are usually prescribed with a progestin, particularly for women with intact uteri. Some studies suggest that sequential use of progestins may increase risk; however, the moderating effects of usage patterns or patient characteristics, including body mass index (BMI), are unknown. We evaluated menopausal hormone use and incident endometrial cancer (n = 885) in 68,419 postmenopausal women with intact uteri enrolled in the National Institutes of Health‐American Association of Retired Persons Diet and Health study. Participants completed a risk factor questionnaire in 1996–1997 and were followed up through 2006. Hazard rate ratios (RRs) and 95% confidence intervals (CIs) were estimated using Cox regression. Among 19,131 women reporting exclusive estrogen plus progestin use, 176 developed endometrial cancer (RR = 0.88; 95% CI = 0.74–1.06). Long‐duration (≥10 years) sequential (<15 days progestin per month) estrogen plus progestin use was positively associated with risk (RR = 1.88; 95% CI = 1.36–2.60], whereas continuous (>25 days progestin per month) estrogen plus progestin use was associated with a decreased risk (RR = 0.64; 95% CI = 0.49–0.83). Increased risk for sequential estrogen plus progestin was seen only among thin‐to‐normal weight women (BMI < 25 kg/m 2; RR = 2.53). Our findings support that specific categories of estrogen plus progestin use increases endometrial cancer risk, specifically long durations of sequential progestins, whereas decreased endometrial cancer risk was observed for users of short‐duration continuous progestins. Risks were highest among thin‐to‐normal weight women, presumably reflecting their lower endogenous estrogen levels, suggesting that menopausal hormones and obesity increase endometrial cancer through common etiologic pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.27623

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 29

  1. Reis L, 2010, SEER Cancer Statistics Review, 1975–2005
  2. 10.1056/NEJM197512042932302 · DOI · Paper page
  3. 10.1056/NEJM197512042932303 · DOI · Paper page
  4. 10.1016/0029-7844(94)00383-O · DOI · Paper page
  5. 10.1158/1055-9965.EPI-05-0111 · DOI · Paper page
  6. 10.1097/AOG.0b013e3181bea950 · DOI
  7. 10.1002/ijc.24672 · DOI
  8. 10.1093/aje/kwq300 · DOI · Paper page
  9. 10.1093/jnci/89.15.1110 · DOI · Paper page
  10. 10.1093/jnci/91.13.1131 · DOI · Paper page
  11. 10.1023/A:1023066304473 · DOI
  12. 10.1016/j.ajog.2007.01.019 · DOI
  13. 10.1158/1055-9965.EPI-09-0712 · DOI
  14. 10.1002/cncr.22525 · doi:10.1002/cncr.22525
  15. 10.1158/1055-9965.EPI-06-0675 · DOI · Paper page
  16. 10.1093/aje/154.12.1119 · DOI · Paper page
  17. 10.1001/jama.288.3.321 · DOI · Paper page
  18. 10.1016/S0895-4356(99)00192-4 · doi:10.1016/s0895-4356(99)00192-4
  19. Whitehead MI, 1987, The effects of estrogens and progestogens on the endometrium. Modern approach to treatment, Obstet Gynecol Clin North Am, 14, 299, 10.1016/S0889-8545(21)00584-2 · doi:10.1016/s0889-8545(21)00584-2
  20. 10.1093/aje/kwj316 · DOI
  21. 10.1007/s10552-011-9840-6 · doi:10.1007/s10552-011-9840-6
  22. 10.1007/s10552-006-0113-8 · DOI · Paper page
  23. 10.1007/s10552-010-9568-8 · DOI
  24. 10.1158/1055-9965.EPI-07-2567 · DOI · Paper page
  25. 10.1016/S0140-6736(05)66455-0 · DOI · Paper page
  26. 10.1016/j.annepidem.2011.01.003 · DOI
  27. 10.1080/13595220152601837 · doi:10.1080/13595220152601837
  28. 10.1016/S1047-2797(00)00186-1 · doi:10.1016/s1047-2797(00)00186-1
  29. 10.1038/oby.2007.504 · DOI · Paper page

Cited by

See all 71

Metadata

Authors
Trabert, B., Wentzensen, N., Yang, H. P., Sherman, M. E., Hollenbeck, A. R., Park, Y., & Brinton, L. A.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2012-08-30
Volume
132
Issue
2
Pages
417-426
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2091303521
Cited by
71
References
5
FWCI
4.37
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? https://app.cochat.ai/papers/10.1002/ijc.27623
The paper
Trabert, B., Wentzensen, N., Yang, H. P., Sherman, M. E., Hollenbeck, A. R., Park, Y., & Brinton, L. A. (2013). Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? International Journal of Cancer. https://doi.org/10.1002/ijc.27623

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.